HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Abstract
Naltrexone (NTX) is an opioid antagonist used for treatment of narcotic dependence and alcoholism. Transdermal naltrexone delivery is desirable to help improve patient compliance. The purpose of this study was to increase the delivery rate of NTX across human skin by using lipophilic alkyl ester prodrugs. Straight-chain naltrexone-3-alkyl ester prodrugs of 2-7 carbons in chain length were synthesized and evaluated. In vitro human skin permeation rates were measured using a flow-through diffusion cell system. The melting points, solubilities, and skin disposition of the drugs were determined. The prodrugs were almost completely hydrolyzed on passing through the skin and appeared as NTX in the receiver compartment. The mean NTX flux from the prodrug-saturated solutions exceeded the flux of NTX base by approximately 2-7-fold. The amount of drug detected in the skin was significantly greater after treatment with the prodrug solutions compared with treatment with NTX base. The extent of parent drug (NTX) regeneration in the intact skin ranged from 28 to 91%. Higher NTX regeneration percentages in skin appeared to correlate with increased drug delivery rates. Definitively, the highly oil-soluble prodrugs provide a higher NTX flux across human skin in vitro and undergo significant metabolic conversion in the skin.
AuthorsAudra L Stinchcomb, Peter W Swaan, Opinya Ekabo, Kathleen K Harris, Jennifer Browe, Dana C Hammell, Todd A Cooperman, Michael Pearsall
JournalJournal of pharmaceutical sciences (J Pharm Sci) Vol. 91 Issue 12 Pg. 2571-8 (Dec 2002) ISSN: 0022-3549 [Print] United States
PMID12434400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2571-2578, 2002
Chemical References
  • Esters
  • Prodrugs
  • Naltrexone
  • Esterases
Topics
  • Biotransformation
  • Diffusion (drug effects)
  • Esterases (chemistry, pharmacokinetics)
  • Esters
  • Humans
  • Naltrexone (chemistry, pharmacokinetics)
  • Prodrugs (chemistry, pharmacokinetics)
  • Skin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: